The Impact of Chemotherapy on Hepatitis B Antibody Titer in Patients with Hematological Malignancies

Creative Commons License

Yagci M., Suyam E., Cakar M. K.

TURKISH JOURNAL OF HEMATOLOGY, cilt.32, sa.3, ss.251-256, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 32 Sayı: 3
  • Basım Tarihi: 2015
  • Doi Numarası: 10.4274/tjh.2013.0342
  • Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.251-256
  • Anahtar Kelimeler: Hepatitis B, Resolved infection, Hepatitis B surface antibody, Hematological malignancy, Chemotherapy, VIRUS REACTIVATION, VIRAL-HEPATITIS, POSITIVE PATIENTS, INFECTION, RISK, MANAGEMENT, PREVENTION, LIVER
  • Gazi Üniversitesi Adresli: Evet

Özet

Objective: To investigate the influence of chemotherapy (CT) on HBsAb titer in patients receiving CT due to hematological malignancy.